My watch list
my.bionity.com  
Login  
MARKET STUDIES

B-Cell Lymphomas – Pipeline Review, H2 2012

Introduction Global Markets Direct’s, 'B-Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeli ...

Memory Pharmaceuticals Corp. - Strategic SWOT Analysis Review

Memory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of drug candidates f ...

Kedem Pharmaceuticals Inc. (GHLV) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Kedem Pharmaceuticals Inc. provides you an in-depth strategic analysis of the company’s businesses and operati ...

Pipeline and Commercial Insight: Moderate to Severe Chronic Nociceptive Pain ...

Introduction The moderate to severe chronic nociceptive pain market has boomed in the years since the removal of generic extended-release oxycodo ...

Colorectal Cancer - Pipeline Review, Q1 2011

Introduction Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, Q1 2011', provides an overview of the Colorectal Cancer therapeutic p ...

Current market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 201 ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriasis. It includes an overview of the tri ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AI ... more

China Chinese Prepared Medicines Mfg. Industry Profile

Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the Chinese prepared medicines mfg. industry in China, a list of ma ... more

Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018

Introduction ”Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile ENT Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment ... more

News on market trends
  • Research from poor countries deserves a fairer hearing

    Academia could be overlooking new ideas from low income nations without realising it, suggests an Imperial College London researcher. Dr Matthew Harris, from Imperial’s School of Public Health and Institute of Global Health Innovation, discusses how unconscious bias could be keeping developed and de more

  • ZEISS Stake in Optec Group

    ZEISS will strengthen its activities in Russia, the Ukraine, the Commonwealth of Independent States (CIS) and Georgia by acquiring a majority stake in the Optec Group, – the long-standing sales and service partner responsible for this territory.With this step, ZEISS is continuing and expanding its a more

  • Recipharm equips Lisbon facility for US and European serialisation

    Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supply more

  • Innovative Extraction Technologies

    Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials and use raw more

  • STA Pharmaceutical to open new transition metal catalysis center

    The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated more

  • Evonik opens site in France’s Cosmetic Valley

    At the end of September, Evonik celebrated the opening of the new site for its Evonik Advanced Botanicals subsidiary in Tours (France). Now part of the Personal Care Business Line, the new subsidiary was created in 2016 when Evonik acquired experts in biotechnological production of plant-based activ more

  • AkzoNobel expands pharma salt production in Denmark

    AkzoNobel's Specialty Chemicals business has completed the expansion of a production site in Denmark which supplies essential pharmaceutical grade salt for the healthcare industry. Located in Mariager, the products supplied by the facility are used as an active pharmaceutical ingredient in various a more

  • Merck Invests in its Biotech Manufacturing Site in Bari

    Merck will invest € 35 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy. The announcement was made as part of an event celebrating the 25th anniversary of the site and its leading role on the science and technology more

  • Recipharm signs manufacturing agreement and acquires facility in Spain

    Recipharm AB announces that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products. Recipharm will also acquire a manufacturing facility currently employing approximately 200 people located in Lega more

  • Merck to acquire Natrix Separations

    Merck announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. The transaction is expected to close in Q3 of 2017. Financial details were not disclosed. Natrix is known for its unique more

New market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenari ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also invol ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE